(PharmaNewsWire.Com, January 24, 2020 ) Medical Robots Transforming Healthcare that has been causing a paradigm shift in healthcare as it improves the quality of patient care. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate the adoption of medical robots.
To increase the access to this expensive technology, manufacturers have been offering varied financing options to the healthcare providers. Some of the options include leasing, pay-per-use, bundled payments, rental agreements, and expanded payment terms, among others. In addition, the manufacturers are coming up with a low-cost products such as Zeno R25 (rehabilitation robot by RoboKind) and SurgiBot (by TransEntrix). Moreover, some of the companies follow differential pricing across geographies. For instance, Europe being a price sensitive market is offered the da Vinci robot at discounted price.
Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.
This report provides qualitative assessment of medical robots (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy) in terms of prices of different types of robots, price variation by application & geography, reimbursements of medical robots, buying cycle, financing options available to the end-users to access the technology, price wars among market players, marketing & promotional strategies focused by the vendors, and cost-benefit assessment based on research studies and expert opinions.
The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700. To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
